These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 25730849)

  • 1. β-Catenin in dendritic cells exerts opposite functions in cross-priming and maintenance of CD8+ T cells through regulation of IL-10.
    Fu C; Liang X; Cui W; Ober-Blöbaum JL; Vazzana J; Shrikant PA; Lee KP; Clausen BE; Mellman I; Jiang A
    Proc Natl Acad Sci U S A; 2015 Mar; 112(9):2823-8. PubMed ID: 25730849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-catenin mediates tumor-induced immunosuppression by inhibiting cross-priming of CD8⁺ T cells.
    Liang X; Fu C; Cui W; Ober-Blöbaum JL; Zahner SP; Shrikant PA; Clausen BE; Flavell RA; Mellman I; Jiang A
    J Leukoc Biol; 2014 Jan; 95(1):179-90. PubMed ID: 24023259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GSK-3β in Dendritic Cells Exerts Opposite Functions in Regulating Cross-Priming and Memory CD8 T Cell Responses Independent of β-Catenin.
    Fu C; Wang J; Ma T; Yin C; Zhou L; Clausen BE; Mi QS; Jiang A
    Vaccines (Basel); 2024 Sep; 12(9):. PubMed ID: 39340067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt-β-Catenin Signaling in Human Dendritic Cells Mediates Regulatory T-Cell Responses to Fungi via the PD-L1 Pathway.
    Karnam A; Bonam SR; Rambabu N; Wong SSW; Aimanianda V; Bayry J
    mBio; 2021 Dec; 12(6):e0282421. PubMed ID: 34781737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-catenin signaling drives differentiation and proinflammatory function of IRF8-dependent dendritic cells.
    Cohen SB; Smith NL; McDougal C; Pepper M; Shah S; Yap GS; Acha-Orbea H; Jiang A; Clausen BE; Rudd BD; Denkers EY
    J Immunol; 2015 Jan; 194(1):210-22. PubMed ID: 25416805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza A infection enhances cross-priming of CD8+ T cells to cell-associated antigens in a TLR7- and type I IFN-dependent fashion.
    Wei J; Waithman J; Lata R; Mifsud NA; Cebon J; Kay T; Smyth MJ; Sadler AJ; Chen W
    J Immunol; 2010 Nov; 185(10):6013-22. PubMed ID: 20956347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Catenin in Dendritic Cells Negatively Regulates CD8 T Cell Immune Responses through the Immune Checkpoint Molecule Tim-3.
    Fu C; Wang J; Ma T; Yin C; Zhou L; Clausen BE; Mi QS; Jiang A
    Vaccines (Basel); 2024 Apr; 12(5):. PubMed ID: 38793711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selectively impaired CD8+ but not CD4+ T cell cycle arrest during priming as a consequence of dendritic cell interaction with plasmodium-infected red cells.
    Pouniotis DS; Proudfoot O; Bogdanoska V; Scalzo K; Kovacevic S; Coppel RL; Plebanski M
    J Immunol; 2005 Sep; 175(6):3525-33. PubMed ID: 16148095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic Cell-Specific Deletion of β-Catenin Results in Fewer Regulatory T-Cells without Exacerbating Autoimmune Collagen-Induced Arthritis.
    Alves CH; Ober-Blöbaum JL; Brouwers-Haspels I; Asmawidjaja PS; Mus AM; Razawy W; Molendijk M; Clausen BE; Lubberts E
    PLoS One; 2015; 10(11):e0142972. PubMed ID: 26587585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. siRNA silencing of PD-1 ligands on dendritic cell vaccines boosts the expansion of minor histocompatibility antigen-specific CD8(+) T cells in NOD/SCID/IL2Rg(null) mice.
    van der Waart AB; Fredrix H; van der Voort R; Schaap N; Hobo W; Dolstra H
    Cancer Immunol Immunother; 2015 May; 64(5):645-54. PubMed ID: 25724840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus-mediated CD40 ligand gene-engineered dendritic cells elicit enhanced CD8(+) cytotoxic T-cell activation and antitumor immunity.
    Liu Y; Zhang X; Zhang W; Chen Z; Chan T; Ali K; Jia Z; Xiang J
    Cancer Gene Ther; 2002 Feb; 9(2):202-8. PubMed ID: 11857039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cells require NIK for CD40-dependent cross-priming of CD8+ T cells.
    Katakam AK; Brightbill H; Franci C; Kung C; Nunez V; Jones C; Peng I; Jeet S; Wu LC; Mellman I; Delamarre L; Austin CD
    Proc Natl Acad Sci U S A; 2015 Nov; 112(47):14664-9. PubMed ID: 26561586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bypassing STAT3-mediated inhibition of the transcriptional regulator ID2 improves the antitumor efficacy of dendritic cells.
    Li HS; Liu C; Xiao Y; Chu F; Liang X; Peng W; Hu J; Neelapu SS; Sun SC; Hwu P; Watowich SS
    Sci Signal; 2016 Sep; 9(447):ra94. PubMed ID: 27678219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.
    Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-induced interleukin 10 suppresses the ability of splenic dendritic cells to stimulate CD4 and CD8 T-cell responses.
    Yang AS; Lattime EC
    Cancer Res; 2003 May; 63(9):2150-7. PubMed ID: 12727833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8+ T cell responses following replication-defective adenovirus serotype 5 immunization are dependent on CD11c+ dendritic cells but show redundancy in their requirement of TLR and nucleotide-binding oligomerization domain-like receptor signaling.
    Lindsay RW; Darrah PA; Quinn KM; Wille-Reece U; Mattei LM; Iwasaki A; Kasturi SP; Pulendran B; Gall JG; Spies AG; Seder RA
    J Immunol; 2010 Aug; 185(3):1513-21. PubMed ID: 20610651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NK cells are required for dendritic cell-based immunotherapy at the time of tumor challenge.
    Bouwer AL; Saunderson SC; Caldwell FJ; Damani TT; Pelham SJ; Dunn AC; Jack RW; Stoitzner P; McLellan AD
    J Immunol; 2014 Mar; 192(5):2514-21. PubMed ID: 24477907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal TLR9 signal converts tolerogenic CD4-8- DCs into immunogenic ones capable of stimulating antitumor immunity via activating CD4+ Th1/Th17 and NK cell responses.
    Zhang X; Munegowda MA; Yuan J; Wei Y; Xiang J
    J Leukoc Biol; 2010 Aug; 88(2):393-403. PubMed ID: 20466823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLR3-Mediated CD8+ Dendritic Cell Activation Is Coupled with Establishment of a Cell-Intrinsic Antiviral State.
    Széles L; Meissner F; Dunand-Sauthier I; Thelemann C; Hersch M; Singovski S; Haller S; Gobet F; Fuertes Marraco SA; Mann M; Garcin D; Acha-Orbea H; Reith W
    J Immunol; 2015 Aug; 195(3):1025-33. PubMed ID: 26101320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.